Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxorubicin Pharmacokinetics and Response in NHL
NCT00969462Phase 4Completed
- Sponsor
- Meir Medical Center
- Start
- Sep 2009
- Primary completion
- Dec 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of doxorubicin in non-Hodgkin lymphoma (NHL), sponsored by Meir Medical Center. Started Sep 2009; status: completed.
02
Drugs
doxorubicin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00969462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00969462.